{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-044741","form_type":"8-K","ticker":"HOTH","cik":"0001711786","company_name":"Hoth Therapeutics, Inc.","filed_at":"2026-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.789586+00:00","generated_at":"2026-05-15T05:48:48.775011+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Hoth Therapeutics resumes ATM equity offering under existing H.C. Wainwright agreement","bullets":["On April 16, 2026, Hoth filed a new prospectus supplement to resume sales of common stock under its ATM agreement with H.C. Wainwright.","The ATM offering was previously suspended on April 1, 2026, but the Sales Agreement remained in effect.","The new prospectus supplement relates to the company's existing effective S-3 registration statement (File No. 333-291566).","No specific terms (size, price, or expected proceeds) were disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-044741","json":"https://secwatch.observer/filing/0001213900-26-044741.json","markdown":"https://secwatch.observer/filing/0001213900-26-044741.md","text":"https://secwatch.observer/filing/0001213900-26-044741.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711786/000121390026044741/0001213900-26-044741-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711786/000121390026044741/ea0286719-8k_hoth.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:48:48.775011+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}